| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 212 | 32.685 | 94.604 | - | - |
| Total Income - EUR | - | - | - | - | - | 212 | 32.685 | 94.605 | - | - |
| Total Expenses - EUR | - | - | - | - | - | 633 | 21.553 | 62.856 | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | -421 | 11.132 | 31.749 | - | - |
| Net Profit/Loss - EUR | - | - | - | - | - | -427 | 10.805 | 30.339 | - | - |
| Employees | - | - | - | - | - | 0 | 1 | 1 | - | - |
Check the financial reports for the company - Neuromed Dr. Vătu Mădălina S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Current Assets | - | - | - | - | - | 137 | 11.305 | 31.069 | - | - |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Receivables | - | - | - | - | - | 0 | 0 | 256 | - | - |
| Cash | - | - | - | - | - | 137 | 11.305 | 30.813 | - | - |
| Shareholders Funds | - | - | - | - | - | -386 | 10.428 | 29.961 | - | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | - | - |
| Debts | - | - | - | - | - | 523 | 877 | 1.108 | - | - |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuromed Dr. Vătu Mădălina S.r.l.